GlassScriptPhysician profile
Bailey Harville
NPI 1346974250
$3,765.92
in general payments reported to CMS, 2019-2025
35 companies · $766 in 2025
The $766 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $558 · 2023: $1,362 · 2024: $1,081 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,208.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $604.36 | 2022-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $545.03 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $485.46 | 2022-2025 | |
| Amgen INC. | $332.42 | 2023-2025 | Otezla, Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.01 | 2022-2025 | Jardiance, Tradjenta, Synjardy |
| Boston Scientific Corporation | $215.14 | 2022-2024 | |
| Lilly USA, LLC | $175.19 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $113.61 | 2023-2025 | |
| Idorsia Pharmaceuticals US INC | $107.04 | 2022-2023 | Quviviq |
| Medtronic, INC. | $96.19 | 2022 | |
| Exact Sciences Corporation | $91.33 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $87.15 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Esperion Therapeutics, INC. | $85.45 | 2023-2025 | Nexletol |
| Corium, LLC | $50.09 | 2023 | Azstarys |
| Kowa Pharmaceuticals America, INC. | $48.74 | 2022-2023 | Seglentis, Livalo |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Harville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.